Page last updated: 2024-12-07

2-hydroxyethyl methacrylate phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-hydroxyethyl methacrylate phosphate: RN given refers to unknown molecular fragment in Chemline [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID104265
SCHEMBL ID66258
MeSH IDM0087156

Synonyms (15)

Synonym
2-hydroxyethyl methacrylate phosphate
52628-03-2
2-propenoic acid, 2-methyl-, 2-hydroxyethyl ester, phosphate
p8914q0zmm ,
2-hydroxyethyl 2-methyl-2-propenoate, phosphate
ec 258-053-2
unii-p8914q0zmm
hydroxyethyl methacrylate, phosphated
2-propenoic acid, 2-methyl-,2-hydroxyethyl ester,phosphate
einecs 258-053-2
SCHEMBL66258
phosphoric acid 2-hydroxyethyl methacrylate ester
AKOS028108475
2-(methacryloxy)ethyl phosphate
2-hydroxyethyl 2-methylprop-2-enoate;phosphoric acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's3 (21.43)18.2507
2000's7 (50.00)29.6817
2010's2 (14.29)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.04 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index39.02 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (6.25%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]